The global 3D Printing Pharmaceuticals market was valued at US$ 309.3 million in 2023 and is anticipated to reach US$ 532.6 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.

3D Printing Pharmaceuticals Market

3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for 3D Printing Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printing Pharmaceuticals.

Report Scope

The 3D Printing Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D Printing Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the 3D Printing Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of 3D Printing Pharmaceuticals Market Report

Report Metric	Details
Report Name	3D Printing Pharmaceuticals Market
Accounted market size in 2023	US$ 309.3 million
Forecasted market size in 2030	US$ 532.6 million
CAGR	8.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	FDM SLS PB SLA SSE DPE DOD MDD MED
Segment by Application	Personalized Pharmacy Nutrients
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA, TNO, Therics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 3D Printing Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 3D Printing Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is 3D Printing Pharmaceuticals Market growing?

Ans: The 3D Printing Pharmaceuticals Market witnessing a CAGR of 8.1% during the forecast period 2024-2030.

What is the 3D Printing Pharmaceuticals Market size in 2030?

Ans: The 3D Printing Pharmaceuticals Market size in 2030 will be US$ 532.6 million.

Who are the main players in the 3D Printing Pharmaceuticals Market report?

Ans: The main players in the 3D Printing Pharmaceuticals Market are Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA, TNO, Therics

What are the Application segmentation covered in the 3D Printing Pharmaceuticals Market report?

Ans: The Applications covered in the 3D Printing Pharmaceuticals Market report are Personalized Pharmacy, Nutrients

What are the Type segmentation covered in the 3D Printing Pharmaceuticals Market report?

Ans: The Types covered in the 3D Printing Pharmaceuticals Market report are FDM, SLS, PB, SLA, SSE, DPE, DOD, MDD, MED

1 3D Printing Pharmaceuticals Market Overview

1.1 Product Overview and Scope of 3D Printing Pharmaceuticals

1.2 3D Printing Pharmaceuticals Segment by Type

1.2.1 Global 3D Printing Pharmaceuticals Market Value Comparison by Type (2024-2030)

1.2.2 FDM

1.2.3 SLS

1.2.4 PB

1.2.5 SLA

1.2.6 SSE

1.2.7 DPE

1.2.8 DOD

1.2.9 MDD

1.2.10 MED

1.3 3D Printing Pharmaceuticals Segment by Application

1.3.1 Global 3D Printing Pharmaceuticals Market Value by Application: (2024-2030)

1.3.2 Personalized Pharmacy

1.3.3 Nutrients

1.4 Global 3D Printing Pharmaceuticals Market Size Estimates and Forecasts

1.4.1 Global 3D Printing Pharmaceuticals Revenue 2019-2030

1.4.2 Global 3D Printing Pharmaceuticals Sales 2019-2030

1.4.3 Global 3D Printing Pharmaceuticals Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 3D Printing Pharmaceuticals Market Competition by Manufacturers

2.1 Global 3D Printing Pharmaceuticals Sales Market Share by Manufacturers (2019-2024)

2.2 Global 3D Printing Pharmaceuticals Revenue Market Share by Manufacturers (2019-2024)

2.3 Global 3D Printing Pharmaceuticals Average Price by Manufacturers (2019-2024)

2.4 Global 3D Printing Pharmaceuticals Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of 3D Printing Pharmaceuticals, Product Type & Application

2.7 3D Printing Pharmaceuticals Market Competitive Situation and Trends

2.7.1 3D Printing Pharmaceuticals Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest 3D Printing Pharmaceuticals Players Market Share by Revenue

2.7.3 Global 3D Printing Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 3D Printing Pharmaceuticals Retrospective Market Scenario by Region

3.1 Global 3D Printing Pharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global 3D Printing Pharmaceuticals Global 3D Printing Pharmaceuticals Sales by Region: 2019-2030

3.2.1 Global 3D Printing Pharmaceuticals Sales by Region: 2019-2024

3.2.2 Global 3D Printing Pharmaceuticals Sales by Region: 2025-2030

3.3 Global 3D Printing Pharmaceuticals Global 3D Printing Pharmaceuticals Revenue by Region: 2019-2030

3.3.1 Global 3D Printing Pharmaceuticals Revenue by Region: 2019-2024

3.3.2 Global 3D Printing Pharmaceuticals Revenue by Region: 2025-2030

3.4 North America 3D Printing Pharmaceuticals Market Facts & Figures by Country

3.4.1 North America 3D Printing Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America 3D Printing Pharmaceuticals Sales by Country (2019-2030)

3.4.3 North America 3D Printing Pharmaceuticals Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe 3D Printing Pharmaceuticals Market Facts & Figures by Country

3.5.1 Europe 3D Printing Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe 3D Printing Pharmaceuticals Sales by Country (2019-2030)

3.5.3 Europe 3D Printing Pharmaceuticals Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific 3D Printing Pharmaceuticals Market Facts & Figures by Country

3.6.1 Asia Pacific 3D Printing Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2019-2030)

3.6.3 Asia Pacific 3D Printing Pharmaceuticals Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America 3D Printing Pharmaceuticals Market Facts & Figures by Country

3.7.1 Latin America 3D Printing Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America 3D Printing Pharmaceuticals Sales by Country (2019-2030)

3.7.3 Latin America 3D Printing Pharmaceuticals Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa 3D Printing Pharmaceuticals Market Facts & Figures by Country

3.8.1 Middle East and Africa 3D Printing Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2019-2030)

3.8.3 Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global 3D Printing Pharmaceuticals Sales by Type (2019-2030)

4.1.1 Global 3D Printing Pharmaceuticals Sales by Type (2019-2024)

4.1.2 Global 3D Printing Pharmaceuticals Sales by Type (2025-2030)

4.1.3 Global 3D Printing Pharmaceuticals Sales Market Share by Type (2019-2030)

4.2 Global 3D Printing Pharmaceuticals Revenue by Type (2019-2030)

4.2.1 Global 3D Printing Pharmaceuticals Revenue by Type (2019-2024)

4.2.2 Global 3D Printing Pharmaceuticals Revenue by Type (2025-2030)

4.2.3 Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2019-2030)

4.3 Global 3D Printing Pharmaceuticals Price by Type (2019-2030)

5 Segment by Application

5.1 Global 3D Printing Pharmaceuticals Sales by Application (2019-2030)

5.1.1 Global 3D Printing Pharmaceuticals Sales by Application (2019-2024)

5.1.2 Global 3D Printing Pharmaceuticals Sales by Application (2025-2030)

5.1.3 Global 3D Printing Pharmaceuticals Sales Market Share by Application (2019-2030)

5.2 Global 3D Printing Pharmaceuticals Revenue by Application (2019-2030)

5.2.1 Global 3D Printing Pharmaceuticals Revenue by Application (2019-2024)

5.2.2 Global 3D Printing Pharmaceuticals Revenue by Application (2025-2030)

5.2.3 Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2019-2030)

5.3 Global 3D Printing Pharmaceuticals Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Triastek,Inc.

6.1.1 Triastek,Inc. Corporation Information

6.1.2 Triastek,Inc. Description and Business Overview

6.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Triastek,Inc. 3D Printing Pharmaceuticals Product Portfolio

6.1.5 Triastek,Inc. Recent Developments/Updates

6.2 Aprecia

6.2.1 Aprecia Corporation Information

6.2.2 Aprecia Description and Business Overview

6.2.3 Aprecia 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Aprecia 3D Printing Pharmaceuticals Product Portfolio

6.2.5 Aprecia Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Corporation Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AstraZeneca 3D Printing Pharmaceuticals Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 FabRx

6.4.1 FabRx Corporation Information

6.4.2 FabRx Description and Business Overview

6.4.3 FabRx 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.4.4 FabRx 3D Printing Pharmaceuticals Product Portfolio

6.4.5 FabRx Recent Developments/Updates

6.5 Multiply Labs

6.5.1 Multiply Labs Corporation Information

6.5.2 Multiply Labs Description and Business Overview

6.5.3 Multiply Labs 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Multiply Labs 3D Printing Pharmaceuticals Product Portfolio

6.5.5 Multiply Labs Recent Developments/Updates

6.6 DiHeSys

6.6.1 DiHeSys Corporation Information

6.6.2 DiHeSys Description and Business Overview

6.6.3 DiHeSys 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.6.4 DiHeSys 3D Printing Pharmaceuticals Product Portfolio

6.6.5 DiHeSys Recent Developments/Updates

6.7 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck 3D Printing Pharmaceuticals Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Merck KGaA

6.8.1 Merck KGaA Corporation Information

6.8.2 Merck KGaA Description and Business Overview

6.8.3 Merck KGaA 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Merck KGaA 3D Printing Pharmaceuticals Product Portfolio

6.8.5 Merck KGaA Recent Developments/Updates

6.9 TNO

6.9.1 TNO Corporation Information

6.9.2 TNO Description and Business Overview

6.9.3 TNO 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.9.4 TNO 3D Printing Pharmaceuticals Product Portfolio

6.9.5 TNO Recent Developments/Updates

6.10 Therics

6.10.1 Therics Corporation Information

6.10.2 Therics Description and Business Overview

6.10.3 Therics 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Therics 3D Printing Pharmaceuticals Product Portfolio

6.10.5 Therics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 3D Printing Pharmaceuticals Industry Chain Analysis

7.2 3D Printing Pharmaceuticals Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 3D Printing Pharmaceuticals Production Mode & Process

7.4 3D Printing Pharmaceuticals Sales and Marketing

7.4.1 3D Printing Pharmaceuticals Sales Channels

7.4.2 3D Printing Pharmaceuticals Distributors

7.5 3D Printing Pharmaceuticals Customers

8 3D Printing Pharmaceuticals Market Dynamics

8.1 3D Printing Pharmaceuticals Industry Trends

8.2 3D Printing Pharmaceuticals Market Drivers

8.3 3D Printing Pharmaceuticals Market Challenges

8.4 3D Printing Pharmaceuticals Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global 3D Printing Pharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global 3D Printing Pharmaceuticals Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global 3D Printing Pharmaceuticals Market Competitive Situation by Manufacturers in 2023

Table 4. Global 3D Printing Pharmaceuticals Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global 3D Printing Pharmaceuticals Sales Market Share by Manufacturers (2019-2024)

Table 6. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global 3D Printing Pharmaceuticals Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market 3D Printing Pharmaceuticals Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of 3D Printing Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of 3D Printing Pharmaceuticals, Product Type & Application

Table 12. Global Key Manufacturers of 3D Printing Pharmaceuticals, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global 3D Printing Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Pharmaceuticals as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global 3D Printing Pharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global 3D Printing Pharmaceuticals Sales by Region (2019-2024) & (K Units)

Table 18. Global 3D Printing Pharmaceuticals Sales Market Share by Region (2019-2024)

Table 19. Global 3D Printing Pharmaceuticals Sales by Region (2025-2030) & (K Units)

Table 20. Global 3D Printing Pharmaceuticals Sales Market Share by Region (2025-2030)

Table 21. Global 3D Printing Pharmaceuticals Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2019-2024)

Table 23. Global 3D Printing Pharmaceuticals Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2025-2030)

Table 25. North America 3D Printing Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America 3D Printing Pharmaceuticals Sales by Country (2019-2024) & (K Units)

Table 27. North America 3D Printing Pharmaceuticals Sales by Country (2025-2030) & (K Units)

Table 28. North America 3D Printing Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America 3D Printing Pharmaceuticals Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe 3D Printing Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe 3D Printing Pharmaceuticals Sales by Country (2019-2024) & (K Units)

Table 32. Europe 3D Printing Pharmaceuticals Sales by Country (2025-2030) & (K Units)

Table 33. Europe 3D Printing Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe 3D Printing Pharmaceuticals Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific 3D Printing Pharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific 3D Printing Pharmaceuticals Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific 3D Printing Pharmaceuticals Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific 3D Printing Pharmaceuticals Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific 3D Printing Pharmaceuticals Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America 3D Printing Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America 3D Printing Pharmaceuticals Sales by Country (2019-2024) & (K Units)

Table 42. Latin America 3D Printing Pharmaceuticals Sales by Country (2025-2030) & (K Units)

Table 43. Latin America 3D Printing Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America 3D Printing Pharmaceuticals Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa 3D Printing Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa 3D Printing Pharmaceuticals Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa 3D Printing Pharmaceuticals Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa 3D Printing Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa 3D Printing Pharmaceuticals Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global 3D Printing Pharmaceuticals Sales (K Units) by Type (2019-2024)

Table 51. Global 3D Printing Pharmaceuticals Sales (K Units) by Type (2025-2030)

Table 52. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2019-2024)

Table 53. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2025-2030)

Table 54. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Type (2019-2024)

Table 55. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Type (2025-2030)

Table 56. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2019-2024)

Table 57. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2025-2030)

Table 58. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Type (2019-2024)

Table 59. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Type (2025-2030)

Table 60. Global 3D Printing Pharmaceuticals Sales (K Units) by Application (2019-2024)

Table 61. Global 3D Printing Pharmaceuticals Sales (K Units) by Application (2025-2030)

Table 62. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2019-2024)

Table 63. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2025-2030)

Table 64. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Application (2019-2024)

Table 65. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Application (2025-2030)

Table 66. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2019-2024)

Table 67. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2025-2030)

Table 68. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Application (2019-2024)

Table 69. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Application (2025-2030)

Table 70. Triastek,Inc. Corporation Information

Table 71. Triastek,Inc. Description and Business Overview

Table 72. Triastek,Inc. 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Triastek,Inc. 3D Printing Pharmaceuticals Product

Table 74. Triastek,Inc. Recent Developments/Updates

Table 75. Aprecia Corporation Information

Table 76. Aprecia Description and Business Overview

Table 77. Aprecia 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Aprecia 3D Printing Pharmaceuticals Product

Table 79. Aprecia Recent Developments/Updates

Table 80. AstraZeneca Corporation Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AstraZeneca 3D Printing Pharmaceuticals Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. FabRx Corporation Information

Table 86. FabRx Description and Business Overview

Table 87. FabRx 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. FabRx 3D Printing Pharmaceuticals Product

Table 89. FabRx Recent Developments/Updates

Table 90. Multiply Labs Corporation Information

Table 91. Multiply Labs Description and Business Overview

Table 92. Multiply Labs 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Multiply Labs 3D Printing Pharmaceuticals Product

Table 94. Multiply Labs Recent Developments/Updates

Table 95. DiHeSys Corporation Information

Table 96. DiHeSys Description and Business Overview

Table 97. DiHeSys 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. DiHeSys 3D Printing Pharmaceuticals Product

Table 99. DiHeSys Recent Developments/Updates

Table 100. Merck Corporation Information

Table 101. Merck Description and Business Overview

Table 102. Merck 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Merck 3D Printing Pharmaceuticals Product

Table 104. Merck Recent Developments/Updates

Table 105. Merck KGaA Corporation Information

Table 106. Merck KGaA Description and Business Overview

Table 107. Merck KGaA 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Merck KGaA 3D Printing Pharmaceuticals Product

Table 109. Merck KGaA Recent Developments/Updates

Table 110. TNO Corporation Information

Table 111. TNO Description and Business Overview

Table 112. TNO 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. TNO 3D Printing Pharmaceuticals Product

Table 114. TNO Recent Developments/Updates

Table 115. Therics Corporation Information

Table 116. Therics Description and Business Overview

Table 117. Therics 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Therics 3D Printing Pharmaceuticals Product

Table 119. Therics Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. 3D Printing Pharmaceuticals Distributors List

Table 123. 3D Printing Pharmaceuticals Customers List

Table 124. 3D Printing Pharmaceuticals Market Trends

Table 125. 3D Printing Pharmaceuticals Market Drivers

Table 126. 3D Printing Pharmaceuticals Market Challenges

Table 127. 3D Printing Pharmaceuticals Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of 3D Printing Pharmaceuticals

Figure 2. Global 3D Printing Pharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global 3D Printing Pharmaceuticals Market Share by Type in 2023 & 2030

Figure 4. FDM Product Picture

Figure 5. SLS Product Picture

Figure 6. PB Product Picture

Figure 7. SLA Product Picture

Figure 8. SSE Product Picture

Figure 9. DPE Product Picture

Figure 10. DOD Product Picture

Figure 11. MDD Product Picture

Figure 12. MED Product Picture

Figure 13. Global 3D Printing Pharmaceuticals Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 14. Global 3D Printing Pharmaceuticals Market Share by Application in 2023 & 2030

Figure 15. Personalized Pharmacy

Figure 16. Nutrients

Figure 17. Global 3D Printing Pharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global 3D Printing Pharmaceuticals Market Size (2019-2030) & (US$ Million)

Figure 19. Global 3D Printing Pharmaceuticals Sales (2019-2030) & (K Units)

Figure 20. Global 3D Printing Pharmaceuticals Average Price (US$/Unit) & (2019-2030)

Figure 21. 3D Printing Pharmaceuticals Report Years Considered

Figure 22. 3D Printing Pharmaceuticals Sales Share by Manufacturers in 2023

Figure 23. Global 3D Printing Pharmaceuticals Revenue Share by Manufacturers in 2023

Figure 24. The Global 5 and 10 Largest 3D Printing Pharmaceuticals Players: Market Share by Revenue in 2023

Figure 25. 3D Printing Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 26. Global 3D Printing Pharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 27. North America 3D Printing Pharmaceuticals Sales Market Share by Country (2019-2030)

Figure 28. North America 3D Printing Pharmaceuticals Revenue Market Share by Country (2019-2030)

Figure 29. United States 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Canada 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Europe 3D Printing Pharmaceuticals Sales Market Share by Country (2019-2030)

Figure 32. Europe 3D Printing Pharmaceuticals Revenue Market Share by Country (2019-2030)

Figure 33. Germany 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. France 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. U.K. 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Italy 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Russia 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Asia Pacific 3D Printing Pharmaceuticals Sales Market Share by Region (2019-2030)

Figure 39. Asia Pacific 3D Printing Pharmaceuticals Revenue Market Share by Region (2019-2030)

Figure 40. China 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Japan 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. South Korea 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. India 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Australia 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. China Taiwan 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Southeast Asia 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America 3D Printing Pharmaceuticals Sales Market Share by Country (2019-2030)

Figure 48. Latin America 3D Printing Pharmaceuticals Revenue Market Share by Country (2019-2030)

Figure 49. Mexico 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa 3D Printing Pharmaceuticals Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa 3D Printing Pharmaceuticals Revenue Market Share by Country (2019-2030)

Figure 54. Turkey 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE 3D Printing Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of 3D Printing Pharmaceuticals by Type (2019-2030)

Figure 58. Global Revenue Market Share of 3D Printing Pharmaceuticals by Type (2019-2030)

Figure 59. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of 3D Printing Pharmaceuticals by Application (2019-2030)

Figure 61. Global Revenue Market Share of 3D Printing Pharmaceuticals by Application (2019-2030)

Figure 62. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Application (2019-2030)

Figure 63. 3D Printing Pharmaceuticals Value Chain

Figure 64. 3D Printing Pharmaceuticals Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions